tiprankstipranks
AMARANTUS BIOSCI INC (AMBS)
OTHER OTC:AMBS
US Market
Holding AMBS?
Track your performance easily

Amarantus Biosci (AMBS) Stock Price & Analysis

30 Followers

AMBS Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

AMBS FAQ

What was AMARANTUS BIOSCI INC’s price range in the past 12 months?
Currently, no data Available
What is AMARANTUS BIOSCI INC’s market cap?
Currently, no data Available
When is AMARANTUS BIOSCI INC’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AMARANTUS BIOSCI INC’s earnings last quarter?
Currently, no data Available
Is AMARANTUS BIOSCI INC overvalued?
According to Wall Street analysts AMARANTUS BIOSCI INC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does AMARANTUS BIOSCI INC pay dividends?
    AMARANTUS BIOSCI INC does not currently pay dividends.
    What is AMARANTUS BIOSCI INC’s EPS estimate?
    AMARANTUS BIOSCI INC’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does AMARANTUS BIOSCI INC have?
    AMARANTUS BIOSCI INC has 368,407,400 shares outstanding.
      What happened to AMARANTUS BIOSCI INC’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of AMARANTUS BIOSCI INC?
      Currently, no hedge funds are holding shares in AMBS
      ---

      Amarantus Biosci Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      AMARANTUS BIOSCI INC

      Amarantus BioScience Holdings, Inc. is a biopharmaceutical company. The company engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Cyclacel Pharmaceuticals
      Soligenix
      TRACON Pharmaceuticals
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis